Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report

doi:10.4240/wjgs.v17.i1.99752

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (207)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

104

Figures (1-5)

Tables (1-1)

Sum=165

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=33

Jan 27, 2025 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Surg. Jan 27, 2025; 17(1): 99752
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.99752

Table 1 Laboratory examinations at diagnosis and endpoint

Variables		Baseline	Endpoint
CBC test	WBC (× 10⁹/L)	7.51	3.19
	RBC (× 10⁹/L)	5.17	4.83
	HGB (g/L)	155	135
	PLT (× 10⁹/L)	314	96
Coagulation test	PT (s)	12.2	11.6
Coagulation test	INR	1.09	1.03
Biochemistry test	ALT (U/L)	25	28
	TBIL (μmol/L)	23.6	17.4
	ALP (U/L)	454	58
	γ-GT (U/L)	77	26
	ALB (g/L)	38.2	40.9
	CREA (μmol/L)	65	57
Tumor markers	AFP (ng/mL)	561.9	1.99
Tumor markers	AFP-L3 (ng/mL)	206.8	Less than 0.908
Serology test	HBV-DNA (IU/mL)	5280	Less than 10
	HBsAg	Positive	Negative
	HBsAb	Negative	Negative
	HBeAg	Negative	Negative
	HBcAb	Positive	Positive
	HBeAb	Positive	Positive

CBC: Complete blood count; WBC: White blood cell; RBC: Red blood cell; HGB: Hemoglobin; PLT: Platelet; PT: Prothrombin time; INR: International normalized ratio; ALT: Alanine transaminase; TBIL: Total bilirubin; ALP: Alkaline phosphatase; γ-GT: γ-glutamyltransferase; ALB: Albumin; CREA: Creatinine; AFP: α-fetoprotein; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B e antigen; HBcAb: Hepatitis B core antibody; HBeAb: Hepatitis B e antibody.

Citation: Zheng XQ, Sun LB, Jin WJ, Liu H, Song WY, Xu H, Wu JS, Wang XJ, Gou CY, Ding HG. Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report. World J Gastrointest Surg 2025; 17(1): 99752
URL: https://www.wjgnet.com/1948-9366/full/v17/i1/99752.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.99752